amyrin acetate has been researched along with Dyslipidemia in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Maurya, R; Puri, A; Rajendran, SM; Shah, P; Siddiqi, MI; Srivastava, A; Yadav, PP | 1 |
1 other study(ies) available for amyrin acetate and Dyslipidemia
Article | Year |
---|---|
β-Amyrin acetate and β-amyrin palmitate as antidyslipidemic agents from Wrightia tomentosa leaves.
Topics: Animals; Apocynaceae; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Cricetinae; Diet, High-Fat; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Dyslipidemias; Hydroxymethylglutaryl CoA Reductases; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypolipidemic Agents; Male; Mesocricetus; Models, Molecular; Molecular Structure; Oleanolic Acid; Plant Leaves; Plants, Medicinal | 2012 |